BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02315 BIOCYTOGEN-B

Trading 11-05 14:45:14

42.580

+0.480

+1.14%

High44.460	Low39.440	Vol3.70M
Open44.460	D1 Closing42.100	Amplitude11.92%
Mkt Cap19.03B	Tradable Cap4.73B	Total Shares447.00M
T/O154.06M	T/O Rate3.34%	Tradable Shares111.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"BIOCYTOGEN-B","latestPrice":42.58,"timestamp":1793861107976,"preClose":42.1,"halted":0,"volume":3702734,"delay":0,"changeRate":0.011401425178147193,"floatShares":111000000,"shares":447000000,"eps":0.5060174776626372,"marketStatus":"Trading","change":0.48,"latestTime":"11-05 14:45:14","open":44.46,"high":44.46,"low":39.44,"amount":154055048,"amplitude":0.11924,"askPrice":42.68,"askSize":2000,"bidPrice":42.58,"bidSize":6500,"shortable":3,"etf":0,"ttmEps":0.9906386535139671,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793866200000},"marketStatusCode":2,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":42.1,"openAndCloseTimeList":[[1793842200000,1793851200000],[1793854800000,1793865600000]],"volumeRatio":2.010748,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"Biocytogen Pharmaceuticals (Beijing) Co.,Ltd.","latestPrice":83.68,"timestamp":1793861110000,"preClose":84.51,"halted":0,"volume":3995000,"delay":0,"premium":"-56.76"}},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"1182517315","title":"Movement Alert｜BIOCYTOGEN-B Falls 5.42% in Regular Trading, Pullback Follows Prior Earnings-Driven Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1182517315","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182517315?lang=en_us&edition=fundamental","pubTime":"2026-11-05 09:51","pubTimestamp":1793843485,"startTime":"0","endTime":"0","summary":"On November 5, BIOCYTOGEN-B fell 5.42% in Regular Trading, trading at HK$41.0, with turnover of HK$26.38 million.The clearest recent catalyst is a short-term pullback after the stock surged more than...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Biocytogen Pulls Back After 17% Surge on Profit Growth","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120225190","title":"Movement Alert｜BIOCYTOGEN-B Intraday Rise 18.17% in Regular Trading, Earnings Strength and Recent Institutional Buying Supported the Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1120225190","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120225190?lang=en_us&edition=fundamental","pubTime":"2026-11-04 14:25","pubTimestamp":1793773522,"startTime":"0","endTime":"0","summary":"On November 4, BIOCYTOGEN-B rose 18.17% intraday in Regular Trading, trading at HK$42.62, with turnover of HK$80.71 million.The move aligns with the most recent market interpretation that the stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"BIOCYTOGEN-B Surges on 173.77% Net Profit Jump and E Fund Buying","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181449509","title":"Movement Alert｜BIOCYTOGEN-B falls 6.31% in Regular Trading, recent institutional stake increases fail to prevent continued share-price pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1181449509","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181449509?lang=en_us&edition=fundamental","pubTime":"2026-11-03 13:23","pubTimestamp":1793683422,"startTime":"0","endTime":"0","summary":"On November 3, BIOCYTOGEN-B fell 6.31% in Regular Trading, trading at HK$36.72, with turnover of HK$28.37 million.The most recent company-specific development was a disclosed on-market purchase by...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Biocytogen drops as FMR buys above current price","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152935524","title":"BIOCYTOGEN-B: FMR LLC Acquires Shares, Long Position Rises to 5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152935524","media":"HK Disclosure","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152935524?lang=en_us&edition=fundamental","pubTime":"2026-11-02 17:35","pubTimestamp":1793612143,"startTime":"0","endTime":"0","summary":"FMR LLC bought 100,500 shares of BIOCYTOGEN-B (02315) on the SEHK open market at an average of HKD 42.3527 per share on October 28, 2026, involving about HKD 4.26 million; as an on-exchange active...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679243615","title":"Biocytogen Pharmaceuticals (SEHK:2315) Stock Sinks Despite Profitable Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2679243615","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679243615?lang=en_us&edition=fundamental","pubTime":"2026-10-30 20:44","pubTimestamp":1793364288,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) just posted its Q3 2026 scorecard and the emotional gap between price and performance is on full display. The stock has fallen sharply over the past month, down about 45%, even as trailing twelve month earnings climbed to ¥371.5 million and net profit margin held at 20.2%. Traders are treating a softer quarter as a verdict. The financials read more like a pause inside a still profitable drug developer that carries a rich 39.1x P/E and a valuation debate...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2315/biocytogen-pharmaceuticals-beijing-shares/news/biocytogen-pharmaceuticals-sehk2315-stock-sinks-despite-prof","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2315/biocytogen-pharmaceuticals-beijing-shares/news/biocytogen-pharmaceuticals-sehk2315-stock-sinks-despite-prof","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161420841","title":"BIOCYTOGEN-B: 易方达基金管理有限公司 Acquires Shares, Long Position Rises to 6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161420841","media":"HK Disclosure","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161420841?lang=en_us&edition=fundamental","pubTime":"2026-10-30 17:24","pubTimestamp":1793352299,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) sees 易方达基金管理有限公司 buy 86,000 shares on the SEHK open market at an average of HKD 41.0028 per share on October 27, 2026, involving about HKD 3.53 million; this was an on-exchange...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111158929","title":"Biocytogen Enters a New Phase of Large-Scale Profitability in the First Three Quarters of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1111158929","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111158929?lang=en_us&edition=fundamental","pubTime":"2026-10-29 17:50","pubTimestamp":1793267420,"startTime":"0","endTime":"0","summary":"On October 29, Biocytogen (02315, 688796.SH) released its 2026 third-quarter report.In the first three quarters, the company achieved operating revenue of 1.403 billion yuan, up 49.09% year on year;...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","BK1161","688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679066475","title":"Biocytogen Pharmaceuticals Posts Higher Q3 Attributable Profit; Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2679066475","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679066475?lang=en_us&edition=fundamental","pubTime":"2026-10-29 17:09","pubTimestamp":1793264978,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals  posted 71.4 million yuan in net profit attributable to shareholders for the third quarter, up 8% from a year earlier.EPS came in at 0.16 yuan, a Thursday filing with the Hong Kong Exchange showed.For the three months ended Sept. 30, operating revenue was 461.4 million yuan, up 44% from the year-ago period, the drugmaker said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688796","BK1161","FCA","02315","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120309842","title":"Biocytogen-B (02315) Surges Over 8% in Early Trading Ahead of Q3 Results; Institutions Bullish on Further Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1120309842","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120309842?lang=en_us&edition=fundamental","pubTime":"2026-10-28 10:18","pubTimestamp":1793153892,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) jumped more than 8% in early trading. As of press time, the stock was up 6.94% at HK$42.82, with a turnover of HK$31.214 million.On the news front, Biocytogen plans to hold a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4585","KCAI","02315","VXUS","BK0216","BK4588","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197422835","title":"Movement Alert｜BIOCYTOGEN-B Falls 5.2% in Regular Trading, Shares Extend Pullback Ahead of October 29 Results Board Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1197422835","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197422835?lang=en_us&edition=fundamental","pubTime":"2026-10-26 10:36","pubTimestamp":1792982187,"startTime":"0","endTime":"0","summary":"On October 26, BIOCYTOGEN-B fell 5.2% in Regular Trading, trading at HK$39.32, with turnover of HK$33.68 million.The most recent public update tied to the stock's weakness is that shares were still...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"BIOCYTOGEN-B Pulls Back Before Oct 29 Board Meeting","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134489441","title":"Movement Alert｜BIOCYTOGEN-B Falls 5.15% in Regular Trading, UBS Downgrade and Earnings Window in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1134489441","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134489441?lang=en_us&edition=fundamental","pubTime":"2026-10-22 10:35","pubTimestamp":1792636545,"startTime":"0","endTime":"0","summary":"On October 22, BIOCYTOGEN-B fell 5.15% in Regular Trading, trading at HK$43.04, with turnover of HK$11.23 million.The clearest recent catalyst is an October 21 media item stating that UBS downgraded...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"UBS Downgrade to Neutral Drags BIOCYTOGEN-B Down","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102388544","title":"Biocytogen Schedules 29 October Board Meeting to Approve Q3 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1102388544","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102388544?lang=en_us&edition=fundamental","pubTime":"2026-10-16 17:02","pubTimestamp":1792141369,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has announced that its board of directors will convene on Thursday, 29 October 2026. The meeting’s primary agenda is to consider and approve the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103256818","title":"Biocytogen-B Climbs Nearly 4% in Morning Trading as Model Animal Business Delivers Standout First-Half Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1103256818","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103256818?lang=en_us&edition=fundamental","pubTime":"2026-10-16 10:40","pubTimestamp":1792118438,"startTime":"0","endTime":"0","summary":"Biocytogen-B (HKEX: 02315) rose more than 6% intraday before settling at a gain of 3.85% at HK$52.55 as of press time, with turnover of HK$24.9591 million.In the first half of 2026, Biocytogen-B...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688796","BK0216","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131571308","title":"Biocytogen-B (02315) Jumps Over 6% in Early Trading; Model Animal Business Shines in First Half, Company Continues to Develop Innovative Animal Models","url":"https://stock-news.laohu8.com/highlight/detail?id=1131571308","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131571308?lang=en_us&edition=fundamental","pubTime":"2026-10-16 09:54","pubTimestamp":1792115658,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, Biocytogen-B (02315) surged more than 6% in early trading. As of press time, it was up 4.64% at HK$52.95, with a turnover of HK$9.3465 million.On the news front, in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688796","02315","BK0216","BK4588","KCAI","BK1161","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118962158","title":"Movement Alert｜BIOCYTOGEN-B Intraday Rise 6.13% in Regular Trading, Rebound Emerges as Prior Institutional Selling Pressure Eases","url":"https://stock-news.laohu8.com/highlight/detail?id=1118962158","media":"Market Focus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118962158?lang=en_us&edition=fundamental","pubTime":"2026-10-16 09:38","pubTimestamp":1792114688,"startTime":"0","endTime":"0","summary":"On October 16, BIOCYTOGEN-B rose 6.13% in regular trading, trading at HK$52.9, with turnover of HK$6.98 million.The move appears linked to a partial easing in market digestion of earlier...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BIOCYTOGEN Rebounds as Institutions Ease Selling Pressure","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105914143","title":"Movement Alert｜BIOCYTOGEN-B Falls 5.08% in Regular Trading, Institutional Selling and Positioning Divergence Continue to Weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=1105914143","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105914143?lang=en_us&edition=fundamental","pubTime":"2026-10-15 13:10","pubTimestamp":1792041006,"startTime":"0","endTime":"0","summary":"On October 15, BIOCYTOGEN-B fell 5.08% in Regular Trading, trading at HK$50.25, with turnover of HK$38.47 million.The move coincided with continued market digestion of heavy institutional selling in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BIOCYTOGEN-B drops as institutions unload HK$210M in A-shares","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110851418","title":"Movement Alert｜BIOCYTOGEN-B Falls 5.1% in Regular Trading, A-share Institutional Selling Continues to Weigh on Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1110851418","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110851418?lang=en_us&edition=fundamental","pubTime":"2026-10-14 14:04","pubTimestamp":1791957849,"startTime":"0","endTime":"0","summary":"On October 14, BIOCYTOGEN-B fell 5.1% in regular trading, trading at HK$53.0, with turnover of HK$64.6865 million.The latest market catalyst points to continued digestion of sharp weakness in the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Institutions Dump $29M in BIOCYTOGEN Shares, Stock Slumps","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144423458","title":"Movement Alert｜BIOCYTOGEN-B Falls 6.44% in Regular Trading, Institutional Sell-off Weighs on Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1144423458","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144423458?lang=en_us&edition=fundamental","pubTime":"2026-10-13 09:35","pubTimestamp":1791855346,"startTime":"0","endTime":"0","summary":"On October 13, BIOCYTOGEN-B fell 6.44% in regular trading, trading at HK$58.45 with turnover of HK$13.992 million. The decline was driven by heavy institutional selling, as A-share Dragon-Tiger list...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Institutional Sell-off Hits BIOCYTOGEN-B","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133860535","title":"Fullgoal Fund Raises Stake in Biocytogen-B (02315) by 64,000 Shares at Approximately HK$76.97 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1133860535","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133860535?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:54","pubTimestamp":1791806052,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on October 7, Fullgoal Fund increased its holdings in Biocytogen-B (02315) by 64,000 shares at a price of HK$76.9719 per share, for a...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02315","BK0216","EWH","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135583929","title":"BIOCYTOGEN-B: Fullgoal Fund Management Disposes of Shares, Long Position Falls to 8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135583929","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135583929?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:15","pubTimestamp":1791450922,"startTime":"0","endTime":"0","summary":"On October 5, 2026, Fullgoal Fund Management Co., Ltd. sold 132,000 H shares of BIOCYTOGEN-B on the SEHK open market at an average of HKD 70.5388 per share, involving approximately HKD 9.31 million....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.4112},{"period":"3month","weight":-0.2421},{"period":"6month","weight":-0.1817},{"period":"1year","weight":0.4281},{"period":"ytd","weight":0.1926}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.005},{"period":"3month","weight":-0.0631},{"period":"6month","weight":-0.0937},{"period":"1year","weight":-0.0783},{"period":"ytd","weight":-0.0668}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Biocytogen Pharmaceuticals (Beijing) Co Ltd is a China-based company primarily engaged in the provision of innovative animal models and pre-clinical pharmaceutical research and development services based on its independently developed gene-editing technology. The Company utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The Company is also engaged in the provision of gene-editing services. The Company operates its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.018702},{"month":2,"riseRate":0.75,"avgChangeRate":0.087225},{"month":3,"riseRate":0.5,"avgChangeRate":0.15364},{"month":4,"riseRate":0.25,"avgChangeRate":-0.063264},{"month":5,"riseRate":0.5,"avgChangeRate":0.097922},{"month":6,"riseRate":0.25,"avgChangeRate":-0.005144},{"month":7,"riseRate":0.5,"avgChangeRate":-0.006831},{"month":8,"riseRate":0.5,"avgChangeRate":-0.010825},{"month":9,"riseRate":0.75,"avgChangeRate":0.129955},{"month":10,"riseRate":0.2,"avgChangeRate":-0.167758},{"month":11,"riseRate":0.6,"avgChangeRate":0.02709},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"BIOCYTOGEN-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BIOCYTOGEN-B(02315) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BIOCYTOGEN-B,02315,BIOCYTOGEN-B股票,BIOCYTOGEN-B股票老虎,BIOCYTOGEN-B股票老虎国际,BIOCYTOGEN-B行情,BIOCYTOGEN-B股票行情,BIOCYTOGEN-B股价,BIOCYTOGEN-B股市,BIOCYTOGEN-B股票价格,BIOCYTOGEN-B股票交易,BIOCYTOGEN-B股票购买,BIOCYTOGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BIOCYTOGEN-B(02315) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}